ABVX vs AMLX Stock Comparison
AMLX currently leads ABVX in this stock comparison, with AIQ scores of 78 vs 35. The clearest difference is momentum.
What is the main difference between ABVX and AMLX?
AMLX leads the current stock comparison as Amylyx Pharmaceuticals, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Abivax S.A. vs Amylyx Pharmaceuticals, Inc.
AMLX leads
AMLX leads by 43 AIQ points, primarily on Momentum and Quality, and the lead has widened from 35 points over 30 sessions. Wall Street currently favors ABVX on target upside.
Stable: 3 of 5 evidence groups support AMLX, its lead is widening, and its signal state is cleanly positive.
Abivax S.A.
Amylyx Pharmaceuticals, Inc.
The Algovestiq AIQ Score currently favors AMLX over ABVX, 78 versus 35 as of Nov 15, 2026. AMLX's advantage is driven primarily by stronger momentum and quality. AMLX also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors ABVX. 3 of 5 covered evidence groups favor AMLX today, and the comparison is rated Stable on stability. AMLX lead: Strengthening — the AIQ differential moved from 35 to 43 points over 30 sessions.
Compare Abivax S.A. and Amylyx Pharmaceuticals, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare ABVX and AMLX against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Momentum34 vs 90AMLX +56
- Quality35 vs 79AMLX +44
- Risk Resilience37 vs 48AMLX +11
3 of 5 evidence groups favor AMLX. AMLX’s edge is concentrated in momentum and quality.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Risk Resilience +4, not enough on its own to move the overall score.
No signal started or stopped since the prior session; its 4 active signals are unchanged.
No factor moved materially.
New signals
- ADX Trend Weakening — neutral, trend, medium horizon
- Accumulation Pattern — bullish, volume, medium horizon (1.14x)
- TRIX Bullish Signal — bullish, momentum, short horizon
AMLX's lead was unchanged in the latest session.
Deeper signal detail for each name lives on its own signals page — ABVX and AMLX both carry a full feed there.
The central trade-off
AMLX (Amylyx Pharmaceuticals, Inc.): the stronger current systematic profile, led by momentum and quality.
ABVX (Abivax S.A.): the counter-case, on analyst expectations.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
AMLXAMLX on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
ABVXABVX on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
AMLXAMLX on the Momentum factor, by 56 points.
Lower downside
AMLXAMLX on Risk Resilience, by 11 points.
Analyst upside
ABVXABVX on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors AMLX, analyst targets favor ABVX. That disagreement is the most useful thing on this page.
| Measure | ABVX | AMLX | Note |
|---|---|---|---|
| Implied upside to target | +61.4% | +58% | ABVX has more room |
| Target dispersion | +26.2% | +37.6% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 12 | 12 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 5 covered evidence groups favor AMLX. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | AMLX | 35 vs 78 |
| Fundamentals | Even | revenue growth 0% vs 0%; EPS growth 30% vs 2.6%; TTM ROE -32.1% vs -6% |
| Valuation | Not covered | Not covered |
| Technicals | AMLX | Price vs 50-day -7.7% vs 2.2%; vs 200-day -22.2% vs 45.6% |
| Risk Resilience | AMLX | Risk Resilience 37 vs 48 |
| Analyst expectations | ABVX | Target upside 61.4% vs 58% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of ABVX and AMLX and are excluded from the count.
AIQ Decision Stability
The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.
- The AIQ gap is wide at 43 points. (supports the conclusion holding)
- The leader's advantage has been widening. (supports the conclusion holding)
- The leader's signal state is cleanly positive. (supports the conclusion holding)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on AMLX.
How the comparison changed
120 daily snapshots · May 27 – Nov 13AMLX lead: Strengthening — the AIQ differential moved from 35 to 43 points over 30 sessions.
- Today
- AMLX +43
- 35 vs 78
- 7 sessions ago
- AMLX +45
- 33 vs 78
- 30 sessions ago
- AMLX +35
- 33 vs 68
- 90 sessions ago
- AMLX +19
- 48 vs 67
The lead changed hands once in this window, most recently on Jun 2 when AMLX moved ahead of ABVX.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
0 bullish / 2 bearish / 2 neutral
Only ABVX
- Death Cross Active — bearish, trend, long horizon (18.68%)
- Downtrend Structure Active — bearish, trend, long horizon
5 bullish / 0 bearish / 2 neutral
Only AMLX
- Golden Cross Active — bullish, trend, long horizon (42.54%)
- Accumulation Pattern — bullish, volume, medium horizon (1.14x)
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- TRIX Bullish Signal — bullish, momentum, short horizon
- Uptrend Structure Active — bullish, trend, long horizon
Both carry 2 more signals that do not separate them: ADX Trend Weakening, ATR Expansion - Breakout Mode.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -2.9%, AIQ 0 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.44%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1ABVX closes the Momentum gap — currently 56 points behind, the largest single contributor to AMLX's edge.
- 2ABVX's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3AMLX's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
Split| Metric | ABVX | AMLX |
|---|---|---|
| Revenue growth (YoY) | 0% | 0% |
| EPS growth (YoY) | 30% | 2.6% |
| Gross margin | 153.1% | 0% |
| Operating margin | 119.5% | 0% |
| Return on equity (TTM) | -32.1% | -6% |
| Debt to equity | 0 | 0.01 |
Performance
AMLX leads 6 of 6 windows| Metric | ABVX | AMLX |
|---|---|---|
| 1 week (5 sessions) | 2.2% | 2.7% |
| 1 month (20 sessions) | -0.6% | 15% |
| 3 months (63 sessions) | -27.5% | 41.3% |
| 6 months (126 sessions) | -23.5% | 128% |
| Year to date | -35.1% | 150.7% |
| 1 year (252 sessions) | -15.3% | 145.7% |
Technicals
AMLX has the stronger structure| Metric | ABVX | AMLX |
|---|---|---|
| RSI (14) | 45.5 | 54.7 |
| ADX (14) | 19.4 | 15.9 |
| Price vs 50-day | -7.7% | 2.2% |
| Price vs 200-day | -22.2% | 45.6% |
| Volatility (1M, annualized) | 47% | 57.6% |
Risk
AMLX is the more resilient| Metric | ABVX | AMLX |
|---|---|---|
| Beta | 1.18 | 1.03 |
| Sharpe ratio | 0.24 | 1.35 |
| Sortino ratio | 0.37 | 3.21 |
| Max drawdown | -50.1% | -33.6% |
| Current drawdown | -39.7% | -23.6% |
| Annualized volatility | 86.4% | 87% |
| Value at risk (95%) | -5.2% | -5.5% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, ABVX or AMLX?
On the Algovestiq AIQ Score, AMLX is the stronger of the two as of Nov 15, 2026, scoring 78 against ABVX's 35. The edge comes from momentum and quality. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is ABVX or AMLX the better buy right now?
AMLX carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Stable — 3 of 5 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.
Why does the AIQ Score favor AMLX over ABVX?
The composite weights Quality, Value, Momentum and Risk Resilience. AMLX leads Momentum by 56 points; AMLX leads Quality by 44 points; AMLX leads Risk Resilience by 11 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, ABVX or AMLX?
Analyst price targets imply +61.4% upside for ABVX and +58% for AMLX, so the Street currently favors ABVX. That points the opposite way to the AIQ Score, which favors AMLX. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, ABVX or AMLX?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, ABVX or AMLX?
ABVX on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, ABVX or AMLX?
AMLX on the Momentum factor, by 56 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, ABVX or AMLX?
AMLX is the more resilient of the two, so the other name carries the higher downside risk. AMLX on Risk Resilience, by 11 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is ABVX more profitable than AMLX?
AMLX leads on the comparable margin measures — gross margin 153.1% vs 0%; operating margin 119.5% vs 0%; ttm roe -32.1% vs -6%.
Is AMLX's lead over ABVX getting stronger or weaker?
AMLX lead: Strengthening — the AIQ differential moved from 35 to 43 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands once in that window, most recently on 2026-06-02, when AMLX moved ahead of ABVX.
What would change the ABVX vs AMLX verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: ABVX closes the Momentum gap — currently 56 points behind, the largest single contributor to AMLX's edge; ABVX's Death Cross Active resolves — a bearish trend rule currently active against it; AMLX's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about ABVX and AMLX?
ABVX: 0 bullish / 2 bearish / 2 neutral. AMLX: 5 bullish / 0 bearish / 2 neutral. The most decision-relevant rule on ABVX is Death Cross Active (bearish, long horizon). On AMLX it is Golden Cross Active (bullish, long horizon).
Compare ABVX and AMLX with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.